This Biotech with Breakout MS Drug Draws Big Investment
A breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
Find the best retirement strategies tailored for your 60s. Make the most of your savings and prepare for a rewarding retirement.
6,694 articlesA breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
The Trade Desk slid again amid reports of agency cautions and analyst downgrades. This piece explains the drivers, wh...
A sharp move in a gold royalty stock can trigger questions for both traders and long-term investors. This article bre...
Across a century and a half, Western Union has defined cross-border payments. Yet fintech competition and shifting co...
As dxlg posts its 2025 numbers, investors should focus on sales trends, margins, and cash flow. This guide breaks dow...
Warren Buffett's move into a big oil stock has investors buzzing. We break down what this means for long-term fans of...
Inside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
I recently allocated just more than $10,000 across three tech stocks to balance growth with risk. Here’s how I chose ...
A single insider sale coincided with a sharp move lower in Sprinklr’s shares, prompting questions about signal versus...
As 2026 nears, one stock stands out for investors: the company that’s about to launch the year’s first blockbuster st...
Investors have watched Micron stock keep going lower despite upbeat earnings. This deep dive explains the forces behi...
A viral parody drawing 110 million views isn’t just a pop culture moment—it also tests money decisions. This guide sh...